Literature DB >> 15957127

Home blood pressure monitoring in CKD.

Martin J Andersen1, Wassim Khawandi, Rajiv Agarwal.   

Abstract

BACKGROUND: Blood pressure (BP) control is the mainstay of stalling the progression of cardiorenal disease, yet the performance characteristics of BPs obtained in the clinic (CBPs) by routine or standardized methods or at home (HBP) in diagnosing hypertension or assessing its control are unknown.
METHODS: Two hundred thirty-two patients (20% black; 4% women; mean age, 67 years; 35% with diabetes) with chronic kidney disease (CKD) underwent a single 24-hour ambulatory BP (ABP) monitoring (ABPM) and concomitant recording of CBP and HBP for 1 week. Hypertension is defined as systolic BP of 130 mm Hg or greater or diastolic BP of 80 mm Hg or greater on average awake 24-hour ABPM.
RESULTS: Average ABP was 135.2 +/- 15.9/75.6 +/- 11.0 mm Hg. Thirty-five percent of patients had isolated systolic hypertension; 3%, isolated diastolic hypertension; 27%, combined systolic and diastolic hypertension; and 35%, normotension or well-controlled BP. The prevalence of "white-coat effect" was estimated as 28% to 30% by means of CBPs and 24% by means of HBPs. Well-controlled BP in the clinic, but poorly controlled BP by means of ABPM, masked hypertension, was seen in 26% to 29% by means of CBPs, but only 13% with HBP monitoring.
CONCLUSION: In patients with CKD, HBP is superior in reducing the misclassification of hypertension caused by the white-coat effect and masked hypertension commonly seen with CBPs. An average HBP of approximately 140/80 mm Hg appears to be the best correlate of hypertension defined by means of ABPM.

Entities:  

Mesh:

Year:  2005        PMID: 15957127     DOI: 10.1053/j.ajkd.2005.02.015

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  43 in total

1.  Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients.

Authors:  Rajiv Agarwal; Martin J Andersen; Robert P Light
Journal:  Am J Nephrol       Date:  2007-10-24       Impact factor: 3.754

2.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

Review 3.  Hypertension in Athletes and Active Populations.

Authors:  Kevin T Schleich; M Kyle Smoot; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

Review 4.  Ambulatory blood pressure monitoring: from old concepts to novel insights.

Authors:  Mehmet Kanbay; Kultigin Turkmen; Tevfik Ecder; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-07-06       Impact factor: 2.370

Review 5.  Practical use of home blood pressure monitoring in chronic kidney disease.

Authors:  Sarah Sanghavi; Joseph A Vassalotti
Journal:  Cardiorenal Med       Date:  2014-06-04       Impact factor: 2.041

Review 6.  Blood Pressure and Mortality in Long-Term Hemodialysis-Time to Move Forward.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Am J Hypertens       Date:  2017-03-01       Impact factor: 2.689

7.  Blood pressure and mortality among hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Hypertension       Date:  2010-01-18       Impact factor: 10.190

8.  Management of Resistant Hypertension: Do Not Give Up on Medication.

Authors:  Eric Judd; David A Calhoun
Journal:  Nephrol Self Assess Program       Date:  2014-03

Review 9.  Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension.

Authors:  Jordana B Cohen; Debbie L Cohen
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

Review 10.  Ambulatory blood pressure and cardiovascular risk in chronic kidney disease.

Authors:  Paolo Palatini
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.